News
Most Read

Turn Therapeutics gets authorisation for Covid-19 therapeutic candidate trial
UAE approves Sputnik V Covid-19 vaccine for emergency use
Fire at Serum Institute of India facility kills five people

Most Recent

Drug Development

Turn Therapeutics gets authorisation for Covid-19 therapeutic candidate trial

22 Jan 2021
Analysis
Sections

Features
Comment
Projects
Most Read

Tackling the ‘silent pandemic’ of AMR: WHO launches the Global Leaders Group
Lilly drug prevents Covid infections in long-term care facilities – leading macroeconomic influencers
PTF: Spotting new Covid-19 variants with genome mapping

Most Recent

Infectious Diseases

Tackling the ‘silent pandemic’ of AMR: WHO launches the Global Leaders Group

22 Jan 2021
Sectors
Sections

Clinical Trials
Supply Chain
Drug Development
Manufacturing
Diseases
Cardiovascular
Central Nervous System
Immunology
Infectious Diseases
Oncology
Respiratory
Most Read

Turn Therapeutics gets authorisation for Covid-19 therapeutic candidate trial
Coronavirus company news summary – Moderna works with Takeda on Japan vaccine trial – Sputnik V authorised for use in the UAE
Tackling the ‘silent pandemic’ of AMR: WHO launches the Global Leaders Group

Most Recent

Drug Development

Turn Therapeutics gets authorisation for Covid-19 therapeutic candidate trial

22 Jan 2021
Themes
Deals
Most Read

Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership
Thermo Fisher Scientific acquires Novasep’s Henogen for $874.5m
NewAmsterdam Pharma raises $196m through Series A funding round

Most Recent

Exploring dark antigens: Enara and Boehringer Ingelheim sign oncology partnership

19 Jan 2021
Companies
Sections

Company A-Z
Company Categories
Product & Services
Company Releases
White Papers
Videos
Most Read

TOTE^® SYSTEMS
RSD
Kiskun Meridian

Most Recent

Manufacturing

TOTE^® SYSTEMS

20 Jan 2021
Magazine
Events

Menu

News
Analysis
Investment
Sectors
Deals
US Election
Disruption
Coronavirus

Partners

Accelerating Clinical Trials
Powder Handling
Simplifying Clinical Trials

Tools

Companies
Reports
Awards
Events
Magazine

The Company

About Us
Contact Us
Advertise With Us
Visit GlobalData

Login
Register

Login
Register

Can approving brolucizumab for diabetic macular oedema redeem the drug’s reputation in the market for retinal diseases?

Powered by

About Us
Editorial Approach
Contact Us
Terms & Conditions
Privacy Policy

© Copyright 2021 Verdict Media Limited.

Lost Password Back ⟶
Login
Register

Lost Password?

Registration is disabled.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Continue Learn more